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Use of intravenous methylene blue for the treatment
of refractory hypotension after cardiopulmonary
bypass
To the Editor:
We read with great interest the article by Yiu, Robin, and
Pattison I titled "Reversal of Refractory Hypotension With
Single-Dose Methylene Blue After Coronary Bypass Surg-
ery." The authors reported the successful reversal of post-car-
diopulmonary bypass (CPB) vasoplegia (defined as systolic
blood pressure < 90 mm Hg associated with low systemic
vascular resistance) with the use of a single dose (2 mglkg) of
intravenous methylene blue, achieving hemodynamic stabili-
ty and rapid weaning (l hour) from high-dose vasoconstrictor
(norepinephrine) support.
We recently used methylene blue in the treatment of a
patient with both severe low cardiac output and refractory
vasoplegia resulting from a post-CPB severe inflammatory
response. Like Yiu, Robin, and Pattison, we noted rapid
restoration of peripheral vascular tone, allowing us to discon-
tinue the high-dose norepinephrine drip by the time the infu-
sion dose was completed.
The patient was a 20-year-old man undergoing aortic valve
replacement for severe aortic stenosis with severe left ven-
tricular dysfunction and moderate pulmonary hypertension.
Fourteen years earlier he had had aggressive radiation thera-
py and chemotherapy for Hodgkin lymphoma, and he had
been on a program of furosemide, digoxin, and enalapril. The
operation was conducted under moderate hypothermia
(28°C) with antegrade/retrograde cold blood cardioplegia.
Operative findings revealed a small, fibrotic, heavily calci-
fied aortic anulus and low-placed stenotic coronary ostia.
After extensive debridement and annular enlargement
(Manouguian type), a No. 19 St Jude Medical mechanical
valve (St Jude Medical, Inc, St Paul, Minn) was implanted
and a vein graft was placed to the left anterior descending
coronary artery. The patient could not be weaned from CPB
despite high-dose inotropic and vasoconstrictor support,
resulting in placement of biventricular mechanical assist
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devices (Thoratec; Thoratec Laboratories, Pleasanton, Calif).
The postoperative course at 48 hours showed refractory
hypotension, marginal cardiac output, and high pulmonary
artery pressures despite the use of high doses of epinephrine,
norepinephrine, dobutamine, milrinone, and inhaled nitric
oxide. The infusion of I% methylene blue, 2 mglkg, over 30
minutes and a second dose given 22 hours later produced the
hemodynamic changes listed in Table I.
The mechanism of systemic inflammatory response syn-
drome after CPB is not completely understood and seems to
be multifactorial. At least part of the inflammatory response
is a consequence of substantial nitric oxide release at the
endothelial level, accounting for the persistent capillary
relaxation and low systemic vascular resistance.2•3 The meth-
ylene blue inhibits the guanylate cyclase enzyme, blunting
the release of nitric oxide and therefore promoting an
increase in the peripheral vascular tone. Andrade and associ-
ates4 reported the successful use of methylene blue to control
the inflammatory response after cardiac operations and in
patients with anaphylactic shock, although those patients had
a more distinct vasodilatory shock with increased cardiac out-
put and index. Methylene blue is used clinically for the treat-
ment of methemoglobinemia and the rare cases of nitroprus-
side toxicity. Few significant secondary effects are described
and include cardiac arrhythmias and coronary vasoconstric-
tion with angina. As in the report by Evora, Roselino, and
Schiaveto,5 our patient had a transient nodal rhythm (5 min-
utes) and ventricular ectopy that disappeared after the infu-
sion rate was slowed. Also, different from that report, we
used a I% concentration instead of the 4% described.
Our patient had a mixed disorder with predominant biven-
tricular dysfunction and the inflammatory response resulting
from II hours of CPB. The infusion of methylene blue allowed
rapid (30 minutes) discontinuation of norepinephrine and a
substantial decrease in the epinephrine requirement for pres-
sure support. Unfortunately, despite the initial hemodynamic
improvement, multiple system organ failure progressively
developed and the patient died on postoperative day 10.
We believe methylene blue may be of value as an addition-
Table I. Hemodynamic changes
Time BP (mean) HR SVR CVP CI PAP (mean) NE E DB MN NO
Dose a 80/51 (62) 130 538 28 3.0 42123 (29) 0.2 0.3 5 0.75 50
I hour 118/59 (80) 110 842 22 1.6 41/24 (29) 0.1 5 0.50 50
2 hour 98/57 (67) 112 800 22 1.6 41/24 (29) 0.1 5 0.75 40
3 hour 100/42 (61) 108 996 18 2.0 37/23 (28) 0.05 5 0.75 40
6 hour 93/44 (60) 84 690 23 2.4 42/24 (29) 0.15 5 0.75 30
Dose 1C 83/45 (59) 109 586 24 2.6 44/29 (33) 0.15 7.5 0.75 20
1 hour 116/62 (81) 115 1058 24 2.6 51/30 (36) 0.15 0.5 0.50 20
4 hour 117/59 (81) 114 991 26 2.4 47/28 (33) 0.15 0.5 0.50
Dose a. 2 mg/kg dose; Bp, blood pressure (mm Hg); SVR. systemic vascular resistance (dynes· seel . cmos); CVP, central venous pressure (mm Hg); C/. cardiac
index (L . min,l . m-2; PAp, pulmonary artery pressure (mm Hg); NE, norepinephrine (llg . kg,l . min-I); E, epinephrine (llg . kg-I. min'I); DB, dobutamine (mg'
kg-I. min'I); MN, milrinone (mg' kg-I. min'I); NO, nitric oxide (ppm: particles per million); K, second dose 72 hours postoperatively (I mg/kg).
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al drug for the treatment of patients with refractory vasople-
gia after CPB. Further research, of course, is needed.
Sebastian Pagni, MD
Erie H. Austin, MD
Department ofSurgery
Division of Thoracic and Cardiovascular Surgery
Jewish Hospital-Rudd Heart and Lung Center
University ofLouisville
201 Abraham Flexner Way, Suite 1200
Louisville, KY 40202
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Notes about axillary cannulation
To the Editor:
We read with interest the comments1,2 on our article about
axillary cannulation for type A aortic dissection,3 and we are
honored by the attention paid to our work.
Since August 1998, axillary cannulation has been used in
13 more patients with type A aortic dissection in our institu-
tion. The axilla has now become our site of choice for arteri-
al perfusion. No brachial plexus injury has been recorded and
no lesion of the axillary artery has occurred. These results
emphasize that direct cannulation is safe when a lateral
approach is used, as well. Moreover, in the past 5 years, we
have performed this lateral vascular access in more than 130
axillo-femoral bypass procedures for peripheral disease with-
out local complications.
We fully agree that the graft interposition technique offers
important advantages in terms of systemic pressure monitoring
and decannulation. However, direct cannulation is more expedi-
tious, an advantage in patients with type A aortic dissection.
Furthermore, it is more difficult to evacuate air from the graft
than from the cannula, and this may be disadvantageous.
Another point of controversy is that the choice of the left axil-
lary artery, instead of the right, precludes the use of this route for
elective cerebral protection. Besides our shared apprehension
about manipulating the innominate artery, another m'\ior concern
remains that of embolization at the beginning of perfusion, which
can be avoided if the left axillary artery is used.
The Journal of Thoracic and
Cardiovascular Surgery
June 2000
To assess this point, we have performed transcranial
Doppler monitoring of the bilateral middle cerebral arteries
in 6 patients treated for acute type A aortic dissection. Three
of them received right axillary cannulation and 3 left axillary
cannulation. Although none of the patients had clinically
detectable consequences, microembolic signals were detect-
ed at the beginning of the perfusion in all patients having
right axillary cannulation, whereas no signal was detected in
the 3 patients with left axillary cannulation.
We have encountered only one difficulty with axillary artery
cannulation that does not occur with femoral artery cannulation.
During total aortic arch replacement for type A aortic dissec-
tion, at the moment of circulatory arrest, the descending aorta
tends to empty. We cannot fill the aorta and the graft retro-
gradely, as we can with femoral artery cannulation. Therefore,
once the anastomosis of the button containing the supra-aortic
branches has been completed, we have too much air to evacu-
ate. From this viewpoint, we agree that right axillary artery can-
nulation provides a theoretical advantage over left axillary
artery cannulation by allowing retrograde washing of air bub-
bles through the common carotid, innominate, and even left
subclavian arteries through the vertebral-basilar system.
Eugenio Neri, MD
Carlo Sassi, MD
Istituta di Chirurgia Cardiovascolare
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Is neck or chest anastomosis preferable during
esophageal resection?
To the Editor:
We read with great interest the article by Johansson and
associates titled "Pharyngeal Reflux After Gastric Pull-up
Esophagectomy With Neck and Chest Anastomoses.'" This
topic is important, controversial, and difficult to study, and
the authors are to be commended for addressing it.
The study design is flawed. It is not clear whether the
groups are similar in tumor stage, demographics, and other
variables that could influence pharyngeal reflux. The type
and complexity of the resections are not specified.
Reconstructions are atypical and variable. No gastric drain-
age procedures were performed; thus the occurrence of
gastric retention, reflux, and reflux-related complications
